These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 19056013

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
    Russell JA, Walley KR, Gordon AC, Cooper DJ, Hébert PC, Singer J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Dieter Ayers for the Vasopressin and Septic Shock Trial Investigators.
    Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
    [Abstract] [Full Text] [Related]

  • 4. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD, Jung R, Fish DN, MacLaren R.
    Ann Pharmacother; 2004 Mar; 38(7-8):1117-22. PubMed ID: 15178740
    [Abstract] [Full Text] [Related]

  • 5. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
    Lupei MI, Beilman GJ, Chipman JG, Mann HJ.
    Chirurgia (Bucur); 2009 Mar; 104(5):575-81. PubMed ID: 19943557
    [Abstract] [Full Text] [Related]

  • 6. Cortisol levels and corticosteroid administration fail to predict mortality in critical illness: the confounding effects of organ dysfunction and sex.
    Rady MY, Johnson DJ, Patel B, Larson J, Helmers R.
    Arch Surg; 2005 Jul; 140(7):661-8; discussion 669. PubMed ID: 16027331
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vasoactive drugs for vasodilatory shock in ICU.
    Holmes CL, Walley KR.
    Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
    [Abstract] [Full Text] [Related]

  • 11. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study.
    Bauer SR, Aloi JJ, Ahrens CL, Yeh JY, Culver DA, Reddy AJ.
    J Crit Care; 2010 Jun; 25(2):362.e7-362.e11. PubMed ID: 19926252
    [Abstract] [Full Text] [Related]

  • 12. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
    Miller JT, Welage LS, Kraft MD, Alaniz C.
    J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
    [Abstract] [Full Text] [Related]

  • 13. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
    Benchekroune S, Karpati PC, Berton C, Nathan C, Mateo J, Chaara M, Riché F, Laisné MJ, Payen D, Mebazaa A.
    J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
    [Abstract] [Full Text] [Related]

  • 14. Low-dose steroid therapy does not affect hemodynamic response in septic shock patients.
    Raurich JM, Llompart-Pou JA, Ibáñez J, Frontera G, Pérez O, García L, Ayestarán JI.
    J Crit Care; 2007 Dec; 22(4):324-9. PubMed ID: 18086404
    [Abstract] [Full Text] [Related]

  • 15. Before-after study of a standardized hospital order set for the management of septic shock.
    Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C, Murphy T, Prentice D, Ruoff BE, Kollef MH.
    Crit Care Med; 2006 Nov; 34(11):2707-13. PubMed ID: 16943733
    [Abstract] [Full Text] [Related]

  • 16. Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock.
    de Jong MF, Beishuizen A, Spijkstra JJ, Groeneveld AB.
    Crit Care Med; 2007 Aug; 35(8):1896-903. PubMed ID: 17568326
    [Abstract] [Full Text] [Related]

  • 17. Adrenal exhaustion in septic patients with vasopressor dependency.
    Guzman JA, Guzman CB.
    J Crit Care; 2007 Dec; 22(4):319-23. PubMed ID: 18086403
    [Abstract] [Full Text] [Related]

  • 18. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR, Carneiro AH, Ribeiro OS, Pereira AC, Portuguese Community-Acquired Sepsis Study Group.
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [Abstract] [Full Text] [Related]

  • 19. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
    Dünser M, Wenzel V, Mayr AJ, Hasibeder WR.
    Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
    [Abstract] [Full Text] [Related]

  • 20. Dear vasopressin, where is your place in septic shock?
    Duenser MW, Hasibeder WR.
    Crit Care; 2005 Apr; 9(2):134-5. PubMed ID: 15774061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.